Journals / Journal of Turkish Spinal Surgery / 2014 / Cilt: 25 - Sayı: 3

Chordoma

Kordoma

Pages
225–231
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Due to the essential anatomical localizations of the tumor, high stage of the tumor at the time of the diagnosis and the need of the sacrification of the important structures during wide resection, a high rate of post operative morbidity may be present.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chordomas are aggressive, locally invasive, rare tumors with a poor diagnosis.
📊
Key Findings & Data:They arise from the remnants of the embryonic notochord.
💡
Conclusion & Impact:Due to the essential anatomical localizations of the tumor, high stage of the tumor at the time of the diagnosis and the need of the sacrification of the important structures during wide resection, a high rate of post operative morbidity may be present.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chordomas are aggressive, locally invasive, rare tumors with a poor diagnosis. They arise from the remnants of the embryonic notochord. As they occur in the whole vertebral column, they respectively occur in the sacrum, skull base and the mobile spine the most. Usually they are diagnosed at a late stage. These tumors are minimally responsive to radiotherapy and chemotherapy, therefore the main part of the treatment is surgical resection. Survival and local control of the tumor depend on the achievement of the wide resection of the tumor in appropriate surgical margins. Due to the essential anatomical localizations of the tumor, high stage of the tumor at the time of the diagnosis and the need of the sacrification of the important structures during wide resection, a high rate of post operative morbidity may be present.

Özet

Kordomalar agresif, lokal invaziv, düşük prognozlu nadir görülen bir tümörlerdir. Embriyonik notokord artıklarından gelişirler. Tüm vertebral kolonu tutabilmekle birlikte en sık sırasıyla sakrum, kafa tabanı ve mobil omurgaları tutarlar. Genelde teşhis edildiklerinde ileri derecede büyümüş olarak bulunurlar. Bu tümörler radyoterapiye ve kemoterapiye düşük derecede yanıt verdiği için tedavinin en önemli bölümünü cerrahi rezeksiyon oluşturur. Hasta sağ kalımı ve tümörün lokal kontrolü yüksek oranda tümörün uygun cerrahi sınırlarla geniş eksizyonunun yapılabilmesine bağlıdır. Tümörün bulunduğu önemli anatomik lokalizasyonlar ve teşhis edildiğinde ilerlemiş olması ve cerrahi tedavi sırasında önemli yapıların rezeke edilmesi sebebiyle geniş eksizyon sonrasında önemli oranda morbidite gelişebilir.

🔖

Cite This Article

AKMAN, Y. E., ATICI, Y., YALÇINKAYA, M., ARIKAN, Y., BALİOĞLU, M. B., KABUKÇUOĞLU, Y. S. (2014). Chordoma. Journal of Turkish Spinal Surgery, Cilt: 25 - Sayı: 3, 225–231. https://ajindex.com/articles/271392

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ariel IM, Verdu C. Chordoma: an analysis of twenty cases treated over a twenty-year span. J Surg Oncol 1975; 7: 27–44
  2. Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V, Dossena G, Gennari L. Chor- doma: natural history and treatment results in 33 cases. J Surg Oncol 1988; 37: 185–191
  3. Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M. Chordoma: natural history and results in 28 patients treated at a single insti- tution. Ann Surg Oncol 2003; 10: 291–296
  4. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J. Prognostic factors in chor- doma of the sacrum and mobile spine: a study of 39 pa- tients. Cancer 2000; 88: 2122–2134
  5. Biagini R, Ruggieri P, Mercuri M, Capanna R, Briccoli A, Perin S, Orsini U, Demitri S, Arlecchini S. Neurologic deficit after resection of the sacrum. Chir Or- gani Mov 1997; 82: 357-372
  6. Bjornsson J, Wold LE, Ebersold MJ, Laws ER. Chordoma of the mobile spine. A clinicopathologic anal- ysis of 40 patients. Cancer 1993; 71: 735–740
  7. Boriani S, Bandiera S, Biagini R, Bacchini P, Bo- riani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN. Chordoma of the mobile spine: Fifty years of experience. Spine 2006; 31: 493-503
  8. Boriani S, Chevalley F, Weinstein JN, Biagini R, Campanacci L, De Iure. Chordoma of the spine above the sacrum. Treatment and outcome in 21 cases. Spine 1996; 21: 1569–1577
  9. Casali PG, Stacchiotti S, Messina A, Tamborini E, Martini C, Ripamonti C, Crippa F, Spreafico C, Colec- chia M, Pilotti S. Imatinib mesylate in 18 advanced chor- doma patients. J Clin Oncol 2005; 23: 9012
  10. Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol 2007; 19: 367- 370
  11. Catton C, O’Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J. Chordoma: long- term follow- up after radical photon irradiation. Radio- ther Oncol 1996; 41: 67–72
  12. Chambers PW, Schwinn CP. Chordoma: a clini- copathologic study of metastasis. Am J Clin Pathol 1979; 72: 765–776
  13. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson Jr RC. Lumbosacral chordoma. Prognostic factors and treatment. Spine1999; 24: 1639–1645
  14. Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus 2003; 15: E9
  15. Fourney DR, Rhines LD, Hentschel SJ. En bloc resection of primary sacral tumors: Classification of sur- gical approaches and outcome. J Neurosurg Spine 2005; 3: 111-112
  16. Fuchs B, Dickey ID,